Abstract
Purpose
To investigate the functional and anatomical outcomes of non-damaging retinal laser therapy (NRT), in cases with chronic central serous chorioretinopathy (CSCR).
Methods
Twenty-three eyes of 23 treatment-naïve chronic CSCR patients were included in this study. The irradiation of 577 nm yellow light was conducted on the serous detachment area after switching over to the NRT algorithm. Anatomical and functional changes after treatments were investigated.
Results
The mean age of the subjects was 48.68 ± 5.93 years (41–61). The mean best-corrected visual acuity (BCVA) and the mean central macular thickness (CMT) values were 0.42 ± 0.12logMAR (0.20–0.70) and 315.69 ± 61.25 µm (223–444) before NRT; and 0.28 ± 0.11logMAR (0.10–0.50) and 223.26 ± 60.91 µm (134–336) at the 2nd month follow-up visit (p < 0.001, for both). At the 2nd-month follow-up visit after NRT, complete resorption of subretinal fluid was observed in 18 eyes (78.3%) and incomplete resorption in five eyes (21.7%). Worse values of BCVA and CMT before NRT were found as increased risk for incomplete resorption (p = 0.002 and ρ = 0.612 for BCVA, and p < 0.001 and ρ = 0.715 for CMT).
Conclusion
Significant functional and anatomical improvements can be observed in the early period after NRT in patients with chronic CSCR. Patients having worse baseline BCVA and CMT have increased risk for incomplete resorption.
Similar content being viewed by others
References
Bujarborua D (2001) Long-term follow-up of idiopathic central serous chorioretinopathy without laser. Acta Ophthalmol Scand 79:417–421
Wang M, Munch IC, Hasler PW et al (2008) Central serous chorioretinopathy. Acta Ophthalmol 86:126–145
Bouzas EA, Karadimas P, Pournaras CJ (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47:431–448
Nicholson B, Noble J, Forooghian F et al (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 58:103–126
Yannuzzi LA (1987) Type-A behavior and central serous chorioretinopathy. Retina 7:111–131
Wong KH, Lau K, Chhablani J et al (2016) Central serous chorioretinopathy: what we have learned so far. Acta Ophthal 94:321–325
van Dijk EHC, Fauser S, Breukink MB et al (2018) Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial. Ophthalmology 125:1547–1555
van Rijssen TJ, van Dijk EHC, Yzer S et al (2019) Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res 73:100770
Ross A, Ross AH, Mohamed Q (2011) Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol 22:166–173
Yannuzzi LA (2010) Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 149:361–363
Chan WM, Lai TY, Lai RY et al (2008) Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina 28:85–93
Maruko I, Iida T, Sugano Y et al (2010) Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117:1792–1799
Yadav NK, Jayadev C, Mohan A et al (2015) Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome. Eye 29:258–264
Mainster MA (1999) Decreasing retinal photocoagulation damage: principles and techniques. Semin Ophthalmol 14:200–209
Koytak A, Erol K, Coskun E et al (2010) Fluorescein angiography guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy. Retina 30:1698–1703
Kim SW, Oh J, Oh IK et al (2009) Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging 40:300–303
Abouammoh MA (2015) Advances in the treatment of central serous chorioretinopathy. Saudi J Ophthalmol 29:278–286
Lavinsky D, Wang J, Huie P et al (2016) Nondamaging retinal laser therapy: rationale and applications to the macula. Invest Ophthalmol Vis Sci 57:2488–2500
Sramek C, Paulus Y, Nomoto H et al (2009) Dynamics of retinal photocoagulation and rupture. J Biomed Opt 14:034007
Lavinsky D, Sramek C, Wang J et al (2014) Subvisible retinal laser therapy: titration algorithm and tissue response. Retina 34:87–97
Sramek C, Mackanos M, Spitler R et al (2011) Non-damaging retinal phototherapy: dynamic range of heat shock protein expression. Invest Ophthalmol Vis Sci 52:1780–1787
Yenari MA, Liu J, Zheng Z et al (2005) Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection. Ann N Y Acad Sci 1053:74–83
Schwartz R, Habot-Wilner Z, Martinez MR, Nutman A et al (2017) Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective study. Acta Ophthalmol 95:610–618
Luttrull JK, Chang DB, Margolis BWL et al (2015) Laser resensitization of medically unresponsive neovascular age-related macular degeneration. Retina 35:1184–1194
Author information
Authors and Affiliations
Contributions
CI, MC, MO wrote the main manuscript text and prepared figures. All authors reviewed the manuscript
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Conflict of interest
Author Cagri Ilhan declares that he has no conflict of interest. Author Mehmet Citirik declares that she has no conflict of interest. Author Mesut Ozdemir declares that he has no conflict of interest.
Human and animals rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ilhan, C., Citirik, M. & Özdemir, M. Non-damaging retinal laser therapy in chronic central serous chorioretinopathy. Int Ophthalmol 43, 2875–2882 (2023). https://doi.org/10.1007/s10792-023-02691-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-023-02691-5